The 2023 CCS/CAIC Antiplatelet Guideline Updates: A Deeper Dive into Muddy Waters
Search
Displaying 341 - 360 of 1578
Invasive and non-invasive characterization of coronary atherosclerotic plaque
Updates from ACC 2024
Trainee involvement in clinical research: lessons learned from the RAPTOR study
TOH Virtual Critical Care Program - Please steal our idea!
AMI Cardiogenic Shock: An Old DanGer with A New Treatment
Coronary Artery Disease in Patients with Diabetes: Current Evidence and Knowledge Gaps
Clinical Practice Update on Optimal Post Cardiac Arrest and Refractory Cardiac Arrest Patient Care
Closing the Gap in Transition and Transfer of Congenital Heart Disease Care
Cardiogenic Shock: Past, present and future
Coronary Microvascular Dysfunction - Noninvasive assessment and Clinical Implication
Beyond Traditional Risk Factors: Cardiac CTA as a Guide for Primary Prevention
The Cardiology-Oncology Referral Clinic is a specialized clinic that provides a comprehensive approach to the management of cancer patients who are at risk of or have experienced cardiac toxicities from their cancer treatments. The clinic also sees patients whose cardiac disease may impact the...
Cardiomyopathy is a condition which affects the ability of the heart muscle to pump effectively. There are different types of cardiomyopathy and different causes.
CardioPrevent® is a heart health program that helps people with risk factors lower their chances of developing cardiovascular disease (CVD). The program accepts individuals who are at moderate to high risk for CVD. Participation requires a referral by a physician or nurse practitioner, and results are shared with the referring physician to support the coordination of care.
This risk assessment tool will ask you questions ranging from your family history to your own personal health.
The Cardiovascular Electrophysiology team is focusing on mechanistic studies of arrhythmogenic heart disease, with the hope of developing novel therapies for cardiac arrhythmias.
Our research focuses on the role of behavioural, cognitive, psychological and social mechanisms and interventions for patients with cardiovascular disease and their partners, with the goal of improving cardiovascular health, mental health, and quality of life outcomes.
We are interested in understanding the fundamental mechanisms of cellular lipid homeostasis, trafficking and metabolism, particularly in lipid-loaded macrophage foam cells. During atherosclerosis, foam cells accumulate in the artery wall and are the precursor of heart disease. While today we have...
PDF and video resources for cardiovascular prevention and rehabilitation.